Skip to content
Magazine Articles
-
Lupin secures first China NMPA approval with Oseltamivir launch
The product will be manufactured and commercialized to support treatment and prevention needs during influenza seasons, with an emphasis on improving availability for younger patients across China.
-
Everest Medicines shareholder CBC Group expands holdings amid strategic expansion
Since December 2025, CBC Group, together with the company’s directors have cumulatively purchased more than 3.062 million shares in the open market, amounting to over HK$113.8 million (US$14.56 million).
-
Moscow deploys AI across the healthcare system with over 60 diagnostic services
Radiologists at the Center now access more than 60 AI services, enabling detection of pathologies across 43 clinical areas.